SK Biopharmaceuticals to develop new anti-seizure medication
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
MicroRNA, a type of endogenous non-coding RNA that can regulate gene expression and protein production, has drawn attention from scientists for its potential to support clinical diagnosis and treatment of various diseases.
Under the partnership agreement, Biorchestra will be responsible for target discovery, selection, and synthesis via its in-house technology and SK Biopharmaceuticals for validation and pre-clinical trials.
Biorchestra has a platform that uses antisense oligonucleotides (ASO) to inhibit and regulate miRNA function, and a proprietary drug delivery system (BDDSTM) that can cross the blood-brain barrier (BBB) and deliver therapeutic RNA to the brain.
The two will also jointly own intellectual property and licensing rights to candidate compounds to be discovered through their research.
[ⓒ Maeil Business Newspaper & mk.co.kr, All rights reserved]
Copyright © 매일경제 & mk.co.kr. 무단 전재, 재배포 및 AI학습 이용 금지
- Taekyung in full swing for green material production using CCU - Pulse by Maeil Business News Korea
- SK Shieldus and SoCar file for preliminary review for IPO - Pulse by Maeil Business News Korea
- Hankook Tire unveils airless tire i-Flex at CES 2022 - Pulse by Maeil Business News Korea
- CJ CheilJedang’s biotech subsidiary debuts under name of CJ Bioscience - Pulse by Maeil Business News Korea
- Hyundai, Kia set best US car sales in 2021, beat Honda for first time - Pulse by Maeil Business News Korea
- 강경준, 상간남 피소…사랑꾼 이미지 타격 [MK픽] - 스타투데이
- AI가 실시간으로 가격도 바꾼다…아마존·우버 성공 뒤엔 ‘다이내믹 프라이싱’
- 서예지, 12월 29일 데뷔 11년 만에 첫 단독 팬미팅 개최 [공식] - MK스포츠
- 이찬원, 이태원 참사에 "노래 못해요" 했다가 봉변 당했다 - 스타투데이
- 양희은·양희경 자매, 오늘(4일) 모친상 - 스타투데이